AGRO on NYSE
Adecoagro
Logo: Adecoagro, CC BY-SA 4.0, via Wikimedia Commons3
Argentine agribusiness company.1
Price unavailable
Last updated Oct 16, 2026.
Overview
2002Founded1
Compare with Green Thumb Industries Inc., Verano Holdings Corp. or Fresh Del Monte Produce, or pick any stock.
- TickerAGRO on NYSE1
- Industryagribusiness, dairy industry1
- Websitewww.adecoagro.com
- Business address28, Boulevard F.W. Raiffeeisen, N/A, N4 L-24114
- Filer categoryAccelerated filer4
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2024
28.6%Gross margin5
12.0%Operating margin5
6.1%Net margin5
16.9%Revenue growth, 20245
6.5%Return on equity5
$68.1MFree cash flow5
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Rice Produced By Third Parties brought in 31% of the revenue Adecoagro broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2023 | 2024 | 2025 |
|---|---|---|---|
| Rice Produced By Third Parties | $22.3M | $700.0K | $13.2M |
| Services | $6.1M | $10.9M | $10.4M |
| Sunflower | $8.3M | $7.6M | $6.9M |
| Mwh Of Energy Produced By Third Parties | $2.4M | $3.2M | $5.1M |
| Cotton | $8.4M | $3.9M | $4.9M |
| Rental Income | $1.2M | $2.8M | $1.6M |
| Power Milk Produced By Third Parties | $800.0K | $300.0K |
Business segments
Farming brought in 52% of the revenue Adecoagro broke down this way in fiscal 2025.
Business segments by year
| Business segments | 2023 | 2024 | 2025 |
|---|---|---|---|
| Farming | $720.1M | $768.4M | $757.9M |
| Sugar, Ethanol and Energy | $722.3M | $708.0M | $656.9M |
| Fertilizers | $31.1M |
Regions
B R brought in 36% of the revenue Adecoagro broke down this way in fiscal 2025.
Regions by year
| Regions | 2023 | 2024 | 2025 |
|---|---|---|---|
| B R | $401.1M | $435.7M | $516.1M |
| AR | $402.2M | $480.7M | $488.9M |
| UY | $632.2M | $551.2M | $432.9M |
| C L | $7.0M | $8.8M | $7.9M |
Where the money goes
Where each dollar of revenue went, fiscal 2024
- Other costs94¢$1.4B
- Profit6¢$92.1M
Out of $1.5B in revenue.5
Where each dollar of operating cash went, fiscal 2024
- Capital spending79¢$260.2M
- Kept or used elsewhere21¢$68.1M
Out of $328.3M of cash from operations.5
Financial statements
No quarterly figures reported.
Every line of the income statement in the latest annual report, as filed.6
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Revenue | $1.4B | $1.5B | $1.3B |
| Cost of revenue | -$1.2B | -$1.2B | -$973.2M |
| Initial recognition and changes in fair value of biological assets and agricultural produce | $95.6M | $143.1M | $87.9M |
| Changes in net realizable value of agricultural produce after harvest | $6.4M | -$28.4M | $1.8M |
| Margin on manufacturing and agricultural activities before operating expenses | $351.3M | $434.8M | $415.4M |
| General and administrative expenses | -$122.1M | -$103.9M | -$70.3M |
| Selling expenses | -$161.1M | -$153.5M | -$129.1M |
| Other operating income, net | $26.3M | $4.8M | $25.6M |
| Profit from operations | $94.3M | $182.3M | $241.6M |
| Finance income | $35.1M | $16.8M | $157.1M |
| Finance costs | -$127.1M | -$166.4M | -$122.1M |
| Other financial results - Net (loss) / gain of inflation effects on monetary items | -$9.2M | $2.4M | $28.8M |
| Financial results, net | -$101.2M | -$147.2M | $63.8M |
| (Loss) / profit before income tax | -$6.9M | $35.1M | $305.4M |
| Income tax benefit / (expense) | $174.0K | $57.0M | -$78.7M |
| (Loss) / profit for the year | -$6.8M | $92.1M | $226.7M |
| Equity holders of the parent | -$8.3M | $92.3M | $226.3M |
| Non-controlling interest | $1.6M | -$239.0K | $430.0K |
| Basic earnings per share (USD per share) | -$0.08 | $0.90 | $2.11 |
| Diluted earnings per share (USD per share) | -$0.08 | $0.90 | $2.10 |
No quarterly figures reported.
Every line of the balance sheet in the latest annual report, as filed.6
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Property, plant and equipment, net | $3.0B | $1.5B | $1.5B |
| Right of use assets | $389.0M | $373.8M | $406.7M |
| Investment property | $24.0M | $33.5M | $33.4M |
| Intangible assets, net | $253.9M | $37.2M | |
| Biological assets | $40.5M | $43.4M | |
| Deferred income tax assets | $23.7M | $15.5M | |
| Trade and other receivables, net | $82.9M | $38.5M | |
| Derivative financial instruments | $1.9M | $5.5M | |
| Other assets | $3.5M | $3.8M | |
| Total Non-Current Assets | $3.8B | $2.1B | |
| Biological assets | $274.3M | $250.5M | |
| Inventories | $306.3M | $289.7M | |
| Trade and other receivables, net | $364.4M | $213.4M | |
| Derivative financial instruments | $1.2M | $4.1M | |
| Short-term investments | $89.8M | $46.1M | |
| Cash and cash equivalents | $383.1M | $211.2M | $339.8M |
| Total Current Assets | $1.4B | $1.0B | |
| TOTAL ASSETS | $5.2B | $3.1B | |
| Share capital | $221.8M | $167.1M | |
| Share premium | $876.1M | $659.4M | |
| Cumulative translation adjustment | -$426.2M | -$413.8M | |
| Equity-settled compensation | $11.4M | $17.3M | |
| Other reserves | $153.2M | $151.3M | |
| Treasury shares | -$7.9M | -$17.0M | |
| Revaluation surplus | $275.7M | $245.3M | |
| Reserve from the sale of non-controlling interests in subsidiaries | $41.6M | $41.6M | |
| Retained earnings | $509.7M | $518.1M | |
| Equity attributable to equity holders of the parent | $1.7B | $1.4B | |
| Non-controlling interest | $136.9M | $39.0M | |
| TOTAL SHAREHOLDERS EQUITY | $1.8B | $1.4B | $1.3B |
| Trade and other payables | $700.0K | $767.0K | |
| Borrowings | $1.4B | $680.0M | |
| Lease liabilities | $296.6M | $287.7M | |
| Deferred income tax liabilities | $728.6M | $330.3M | |
| Payroll and social security liabilities | $567.0K | $1.5M | |
| Derivatives financial instruments | $1.3M | $4.0M | |
| Provisions for other liabilities | $22.3M | $2.2M | |
| Total Non-Current Liabilities | $2.4B | $1.3B | |
| Trade and other payables | $673.2M | $206.9M | |
| Current income tax liabilities | $31.9M | $3.5M | |
| Payroll and social security liabilities | $38.8M | $32.7M | |
| Borrowings | $213.1M | $99.6M | |
| Lease liabilities | $60.0M | $54.4M | |
| Derivative financial instruments | $4.1M | $1.8M | |
| Provisions for other liabilities | $5.5M | $1.5M | |
| Total Current Liabilities | $1.0B | $400.3M | |
| TOTAL LIABILITIES | $3.5B | $1.7B | |
| TOTAL SHAREHOLDERS EQUITY AND LIABILITIES | $5.2B | $3.1B |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.6
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| (Loss) / profit for the year | -$6.8M | $92.1M | $226.7M |
| Income tax expense / (benefit) | -$174.0K | -$57.0M | $78.7M |
| Depreciation | $195.8M | $223.8M | $198.3M |
| Amortization | $2.8M | $2.3M | $1.7M |
| Depreciation of right of use assets | $72.9M | $77.9M | $74.1M |
| (Gain) / loss from the disposal of other property items | -$4.3M | $2.4M | -$4.7M |
| Gain from the sale of farmland and other assets | $0 | -$6.0M | -$6.3M |
| (Insurance recovery) / impairment due to fire | -$4.4M | $14.3M | $0 |
| Net (gain) / loss from the fair value adjustment of Investment properties | -$3.3M | $23.4M | -$10.6M |
| Equity settled share-based compensation granted | $11.9M | $6.7M | $8.6M |
| (Gain) from derivative financial instruments and forwards | -$2.9M | -$1.2M | -$8.6M |
| Interest, finance cost related to lease liabilities and other financial expense, net | $89.8M | $68.3M | $16.4M |
| Initial recognition and changes in fair value of non-harvested biological assets (unrealized) | -$13.4M | $18.3M | $17.7M |
| Changes in net realizable value of agricultural produce after harvest (unrealized) | -$876.0K | $7.3M | -$2.6M |
| Provision and allowances | $3.8M | -$1.8M | $654.0K |
| Tax credits recognized | -$6.1M | -$19.5M | $0 |
| Net loss / (gain) of inflation effects on the monetary items | $9.2M | -$2.4M | -$28.8M |
| Foreign exchange (gain) / losses, net | -$5.8M | $37.6M | -$90.9M |
| Cash flow hedge transfer from equity | $0 | $28.6M | $36.9M |
| Subtotal | $338.1M | $515.1M | $507.0M |
| (Increase) / decrease in trade and other receivables | -$57.2M | -$68.3M | $3.7M |
| Decrease / (increase) in inventories | $43.6M | $3.1M | -$12.4M |
| Increase in biological assets | -$17.8M | -$38.9M | -$23.4M |
| Decrease / (increase) in other assets | $240.0K | -$2.1M | -$37.0K |
| Decrease / (increase) in derivative financial instruments | $3.8M | $21.8M | -$11.2M |
| Decrease in trade and other payables | -$3.1M | -$100.3M | -$43.9M |
| Increase in payroll and social security liabilities | $2.1M | $4.1M | $15.7M |
| Increase in provisions for other liabilities | $1.1M | $1.1M | $803.0K |
| Net cash generated from operating activities before taxes paid | $310.9M | $335.6M | $436.2M |
| Income tax paid | -$2.4M | -$7.3M | -$1.3M |
| Net cash generated from operating activities | $308.5M | $328.3M | $434.9M |
| Acquisition of subsidiaries net of cash and cash equivalents acquired | -$676.0M | -$16.2M | -$3.2M |
| Purchases of property, plant and equipment | -$264.1M | -$260.2M | -$241.6M |
| Purchase of cattle and non-current biological assets | -$139.0K | -$1.9M | -$511.0K |
| Purchases of intangible assets | -$2.0M | -$1.2M | -$1.3M |
| Interest received and others | $28.8M | $7.8M | $62.1M |
| Proceeds from disposal of other property items | $4.7M | $2.3M | $4.1M |
| Proceeds from the sale of farmland and other assets | $3.3M | $23.3M | $33.2M |
| Acquisition of short-term investment | -$313.0M | -$47.9M | -$106.9M |
| Disposals of short-term investment | $295.6M | $62.4M | $142.5M |
| Net cash used in investing activities | -$922.9M | -$231.6M | -$111.6M |
| Proceeds from issuance of shares net of transaction costs | $303.7M | $0 | $0 |
| Proceeds from long-term borrowings | $870.6M | $126.8M | $7.7M |
| Payments of long-term borrowings | -$213.9M | -$105.7M | -$24.1M |
| Proceeds from short-term borrowings | $279.9M | $169.9M | $448.5M |
| Payments of short-term borrowings | -$256.3M | -$239.9M | -$420.3M |
| Proceeds from exercise of employee share options | $45.0K | $99.0K | $214.0K |
| (Payments) / collections of derivatives financial instruments | -$226.0K | $669.0K | -$32.0K |
| Lease payments | -$103.9M | -$98.5M | -$104.1M |
| Purchase of own shares | -$10.2M | -$66.9M | -$26.2M |
| Dividends paid to non-controlling interest | -$95.0K | -$736.0K | $0 |
| Dividends paid to shareholders | -$35.0M | -$35.0M | -$35.0M |
| Net (decrease) / increase in cash and cash equivalents | $171.3M | -$177.2M | $114.6M |
| Interest paid | -$48.7M | -$24.6M | -$55.5M |
| Financing activities | $785.8M | -$274.0M | -$208.7M |
| Effects of exchange rate changes and inflation on cash and cash equivalents | $558.0K | $48.7M | -$5.5M |
| Gains on arbitrage bond, classified as investing activities | $5.9M | $238.0K | $54.7M |
Timeline
Recent filings
- Sep 28, 20266-K
- Sep 18, 20266-K
- Sep 2, 20266-K
- Aug 11, 20266-K
- Jul 20, 20266-K
- May 11, 20266-K
- Apr 29, 202620-F
- Apr 29, 20266-K
- Apr 24, 20266-K
- Apr 22, 20264
- Apr 22, 20264
- Apr 22, 20264
- Apr 22, 20264
- Apr 22, 20264
- Apr 22, 20264
Every filing from the last three years, summarized. The full record is on SEC EDGAR.2
Links
- Websitewww.adecoagro.com1
- X (Twitter)x.com/adecoagroarg1
- Facebookwww.facebook.com/adecoagroarg1
- WikidataQ101429880
- SEC EDGARCIK 1499505
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataAdecoagro on Wikidata
- 2SEC EDGARAdecoagro filings on SEC EDGAR
- 3Wikimedia CommonsAdecoagro logo by Adecoagro, CC BY-SA 4.0
- 4SEC EDGARAdecoagro filings on SEC EDGAR
- 5SEC EDGARAdecoagro 10-K for fiscal 2024
- 6
- 7SEC EDGARAdecoagro 10-K for fiscal 2018
- 8SEC EDGARAdecoagro 10-K for fiscal 2019
- 9SEC EDGARAdecoagro 10-K for fiscal 2020
- 10SEC EDGARAdecoagro 10-K for fiscal 2021
- 11SEC EDGARAdecoagro 10-K for fiscal 2018